ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$5.91
-0.18 (-2.96%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+201.0% upside
Low Target
$13.99
Average Target
$17.79
High Target
$22.90
Current Price
$5.91
Current
$5.91
$5.91
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Scenario Analysis
Bear Case
$13.99
136.7%
Low target
Base Case
$17.79
+201.0%
Avg target
Bull Case
$22.90
+287.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$6.52
-9.3% from high
52-Week Low
$1.52
+288.8% from low
50-Day SMA
$4.51
+31.0% vs SMA
RSI (14)
55.5
Neutral
Target vs 52W High
$17.79
+173.1% vs high
Next Earnings Report
Aug 12, 2026
2d
until earnings
EPS Est: $-0.16
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |